Scott Hultman, MD
WASHINGTON—Autologous skin cell suspension, colloquially known as “spray-on skin,” is an effective and safe means of closing full-thickness wounds, according to findings presented at the 2024 annual meeting of the American Surgical Association. The study is the largest single-center analysis to date of ASCS, which only last year was approved for full-thickness wound closure by the FDA after being approved for partial-thickness thermal wounds